U.S. flag

An official website of the United States government

NM_001372066.1(TFAP2A):c.758G>A (p.Gly253Glu) AND Branchiooculofacial syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 23, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001029733.1

Allele description [Variation Report for NM_001372066.1(TFAP2A):c.758G>A (p.Gly253Glu)]

NM_001372066.1(TFAP2A):c.758G>A (p.Gly253Glu)

Genes:
LOC121740638:BRD4-independent group 4 enhancer GRCh37_chr6:10403277-10404476 [Gene]
TFAP2A-AS2:TFAP2A antisense RNA 2 [Gene - OMIM - HGNC]
TFAP2A:transcription factor AP-2 alpha [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6p24.3
Genomic location:
Preferred name:
NM_001372066.1(TFAP2A):c.758G>A (p.Gly253Glu)
Other names:
NM_003220.2:c.752G>A
HGVS:
  • NC_000006.12:g.10404520C>T
  • NG_016151.1:g.20045G>A
  • NG_075700.1:g.465C>T
  • NM_001032280.3:c.734G>A
  • NM_001042425.3:c.740G>A
  • NM_001372066.1:c.758G>AMANE SELECT
  • NP_001027451.1:p.Gly245Glu
  • NP_001035890.1:p.Gly247Glu
  • NP_001358995.1:p.Gly253Glu
  • NC_000006.11:g.10404753C>T
  • NR_145448.1:n.19C>T
Protein change:
G245E
Links:
dbSNP: rs151344527
NCBI 1000 Genomes Browser:
rs151344527
Molecular consequence:
  • NM_001032280.3:c.734G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042425.3:c.740G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001372066.1:c.758G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_145448.1:n.19C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Branchiooculofacial syndrome (BOFS)
Synonyms:
BOF SYNDROME; BOFS syndrome; Branchial clefts with characteristic facies growth retardation imperforate nasolacrimal duct and premature aging; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007235; MeSH: D019280; MedGen: C0376524; Orphanet: 1297; OMIM: 113620

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001192519HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology - CSER-SouthSeq
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 23, 2019)
de novoresearch

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novoyes1not providednot provided1not providedresearch

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology - CSER-SouthSeq, SCV001192519.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedresearch PubMed (1)

Description

ACMG codes: PS2, PS4M, PM2, PP3

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyes1not providednot provided1not providednot providednot provided

Last Updated: Mar 26, 2023